Javascript must be enabled to continue!
Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery
View through CrossRef
Mammalian reovirus is a double-stranded RNA virus that selectively infects and lyses transformed cells, making it an attractive oncolytic agent. Despite clinical evidence for anti-tumor activity, its efficacy as a stand-alone therapy remains to be improved. The success of future trials can be greatly influenced by the identification and the regulation of the cellular pathways that are important for reovirus replication and oncolysis. Here, we demonstrate that reovirus induces autophagy in several cell lines, evident from the formation of Atg5-Atg12 complexes, microtubule-associated protein 1 light chain 3 (LC3) lipidation, p62 degradation, the appearance of acidic vesicular organelles, and LC3 puncta. Furthermore, in electron microscopic images of reovirus-infected cells, autophagosomes were observed without evident association with viral factories. Using UV-inactivated reovirus, we demonstrate that a productive reovirus infection facilitates the induction of autophagy. Importantly, knock-out cell lines for specific autophagy-related genes revealed that the expression of Atg3 and Atg5 but not Atg13 facilitates reovirus replication. These findings highlight a central and Atg13-independent role for the autophagy machinery in facilitating reovirus infection and contribute to a better understanding of reovirus-host interactions.
Title: Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery
Description:
Mammalian reovirus is a double-stranded RNA virus that selectively infects and lyses transformed cells, making it an attractive oncolytic agent.
Despite clinical evidence for anti-tumor activity, its efficacy as a stand-alone therapy remains to be improved.
The success of future trials can be greatly influenced by the identification and the regulation of the cellular pathways that are important for reovirus replication and oncolysis.
Here, we demonstrate that reovirus induces autophagy in several cell lines, evident from the formation of Atg5-Atg12 complexes, microtubule-associated protein 1 light chain 3 (LC3) lipidation, p62 degradation, the appearance of acidic vesicular organelles, and LC3 puncta.
Furthermore, in electron microscopic images of reovirus-infected cells, autophagosomes were observed without evident association with viral factories.
Using UV-inactivated reovirus, we demonstrate that a productive reovirus infection facilitates the induction of autophagy.
Importantly, knock-out cell lines for specific autophagy-related genes revealed that the expression of Atg3 and Atg5 but not Atg13 facilitates reovirus replication.
These findings highlight a central and Atg13-independent role for the autophagy machinery in facilitating reovirus infection and contribute to a better understanding of reovirus-host interactions.
Related Results
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy
Background
Many solid tumors do not respond to immunotherapy due to their immunologically cold tumor microenvironment (TME). We and others found that oncolytic vi...
Abstract 1779: Selective oncolysis of multiple myeloma cells by reovirus is mediated through apoptosis
Abstract 1779: Selective oncolysis of multiple myeloma cells by reovirus is mediated through apoptosis
Abstract
Introduction: Multiple myeloma (MM) is an incurable hematologic malignancy that accounts for 10% of hematopoietic neoplasms. Recently we have demonstrated t...
Abstract 591: Reovirus is oncolytic towards organ specific and highly metastatic lung cancer cells: Possible mechanisms of action.
Abstract 591: Reovirus is oncolytic towards organ specific and highly metastatic lung cancer cells: Possible mechanisms of action.
Abstract
Introduction: Metastasis from lung adenocarcinoma can occur rapidly to multiple organs within months of diagnosis. Despite early diagnosis and surgical remo...
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
Background
T-cell-engaging CD3-bispecific antibodies (CD3-bsAbs) are promising modalities for cancer immunotherapy. Although this therapy has reached clinical pra...
Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells
Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells
AbstractThe mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy. One of the bottlenecks that hampers its antitumour efficacy in vivo is ...
Non-canonical cell death by reassortant reovirus
Non-canonical cell death by reassortant reovirus
Abstract
Triple-negative breast cancer (TNBC) constitutes 12% of all breast cancer and is associated with worse prognosis compared to other subty...
Data from Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
Data from Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
<div>Abstract<p><b>Purpose:</b> Despite the recent advances made in the treatment of multiple myeloma, the disease still remains incurable. The oncolytic po...
Data from Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
Data from Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
<div>Abstract<p><b>Purpose:</b> Despite the recent advances made in the treatment of multiple myeloma, the disease still remains incurable. The oncolytic po...

